Why the study?
CAD is a leading cause of global morbidity and mortality with rising prevalence in developing nations like India, highlighting the need to evaluate risk factors, multimorbidity, and polypharmacy to optimize care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Inamdar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: